












Eta Atolia
CEO at TareBio
Founder & CEO, TareBio (YC S26). MD-PhD from UCLA-Caltech, where she built a novel platform that develops vaccines for any cancer or infection in weeks, funded by the Gates Foundation. BS in Biology from MIT. Conducted research at the Koch Institute, Harvard Medical School, and the Weizmann. Select Awards: UCLA MD-PhD Merit Scholar, UCLA TDG Senior Fellow, MIT iGEM Gold Medal, MIT IDEAs winner, MIT Dean Advisory Group, WhiteHouse Science Fair, Bessie Lawrence Scholar, Intel STS Finalist
Previously at
Ucla-Caltech Medical Scientist Training Program

Harvard Medical School

Massachusetts Institute of Technology
Weizmann Institute of Science

National High Magnetic Field Laboratory
Alumnus of

UCLA-Caltech Medical Scientist Training Program

Massachusetts Institute of Technology